What the Research Says
Sulforaphane is a bioactive compound derived from cruciferous vegetables such as broccoli and Brussels sprouts. It exerts its health benefits through activation of the Nrf2 pathway, which enhances antioxidant defenses and detoxification processes (Talalay et al., 1992). A randomized controlled trial by Egner et al. (2014) demonstrated that sulforaphane, administered as a broccoli sprout beverage, significantly increased the excretion of airborne pollutants in a Chinese population, underscoring its potential role in detoxification support.
Recent studies have explored sulforaphane's therapeutic applications across various conditions. Axelsson et al. (2017) found that sulforaphane improves blood sugar control in individuals with type 2 diabetes by reducing hepatic glucose production. Additionally, Guo et al. (2025) conducted a meta-analysis of five studies involving 129 patients with autism spectrum disorder (ASD), revealing significant improvements in irritability and hyperactivity symptoms, suggesting sulforaphane as a potential complementary treatment.
The bioavailability of sulforaphane is influenced by its formulation. Products containing both glucoraphanin and myrosinase, or stabilized pre-formed sulforaphane, are preferred due to the enzyme's role in converting glucoraphanin into active sulforaphane (Conzatti et al., 2014). Home cultivation of broccoli sprouts is also a cost-effective method for obtaining sulforaphane.
